Information Provided By:
Fly News Breaks for November 2, 2018
CCRN
Nov 2, 2018 | 09:10 EDT
Lake Street analyst Brooks O'Neil upgraded Cross Country Healthcare to Buy and raised his price target for the shares to $12 from $10. The company's orders in Q3 grew 50% in comparison to Q2 and reached the highest level since March 2017, O'Neil tells investors in a research note. Further, he notes that Cross Country's organic revenue growth is expected to return in fiscal 2019 as the headwinds the company has been facing are likely to diminish. O'Neil believes it is time to buy shares of Cross Country Healthcare.
News For CCRN From the Last 2 Days
There are no results for your query CCRN
I agree to the thefly.com's disclaimer & terms of use
About Privacy Terms of Use

© 1996-2018 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.